Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $2.94 Million - $3.47 Million
-13,715 Reduced 33.96%
26,674 $5.92 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $6.75 Million - $8.22 Million
29,873 Added 284.07%
40,389 $9.76 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $2.41 Million - $3.06 Million
10,516 New
10,516 $2.76 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $1.24 Million - $1.38 Million
5,389 Added 208.88%
7,969 $1.94 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $565,716 - $625,830
2,580 New
2,580 $624,000
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $14.7 Million - $17.6 Million
-84,190 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$166.7 - $195.41 $14 Million - $16.5 Million
84,190 New
84,190 $15.5 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $1.12 Million - $1.31 Million
-6,294 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $140,264 - $158,129
-757 Reduced 10.74%
6,294 $1.31 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $810,157 - $909,982
4,879 Added 224.63%
7,051 $1.3 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $368,001 - $430,056
2,172 New
2,172 $370,000
Q3 2017

Nov 14, 2017

SELL
$167.29 - $191.0 $4.02 Million - $4.59 Million
-24,042 Closed
0 $0
Q2 2017

Nov 09, 2017

BUY
N/A
24,042
24,042 $4.14 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.